The business of healthcare innovation
Title By: Burns, Lawton R [Edited by]
Material type:![](/opac-tmpl/lib/famfamfam/BK.png)
Summary:
"Perhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional $6.3 billion in funding for the National Institutes of Health (NIH) and other agencies"--
No physical items for this record
Includes index.
"Perhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional $6.3 billion in funding for the National Institutes of Health (NIH) and other agencies"--